Cure8 research brief
SRCEUS may offer higher-resolution, noninvasive assessment of intestinal microvascular changes that correspond to Crohn disease activity, which could improve monitoring and reduce reliance on invasive tests.
Clinicians using bowel ultrasound; radiologists and sonographers; IBD researchers; patients and caregivers interested in noninvasive disease monitoring.
This Radiology abstract reports a prospective clinical study testing super-resolution contrast-enhanced ultrasound (SRCEUS) to assess Crohn disease activity in the terminal ileum or colon.
The study compared SRCEUS with B‑mode ultrasound, color Doppler flow imaging, and conventional contrast‑enhanced US in 54 participants grouped by endoscopic activity (remission/mild vs moderate/severe).
SRCEUS vascular metrics (for example, maximum and mean density, mean velocity, vascular density ratio) were higher in the moderate/severe group, and a combined model including the vascular density ratio and the International Bowel Ultrasound Segmental Activity Score showed strong discrimination (AUC 0.94).
SRCEUS performed better than CDFI and conventional CEUS and was similar to SRCEUS alone in diagnostic performance as reported in the abstract.
Based on the Radiology abstract via Europe PMC. Study size was modest (54 participants); full article and supplemental materials would clarify methods, reproducibility, and applicability in routine practice.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Noninvasive intestinal ultrasound with superb microvascular imaging (SMI) may help predict the presence and size of endoscopic ulcers in the terminal ileum of people with Crohn’s disease. That could improve noninvasive...
Standardized intestinal ultrasound scoring could help non-invasively monitor Crohn’s disease activity and reduce reliance on colonoscopy for some assessments. A high-sensitivity IUS score may be useful to rule out...
This study suggests intestinal ultrasound findings early after diagnosis — especially achieving “transmural remission” within 3 months — may predict better 1-year outcomes (sustained steroid-free remission and less need...
